Decision Making in Indeterminate Thyroid Nodules and the Role of Molecular Testing - 27/06/19
Résumé |
Cytologically indeterminate thyroid nodules are associated with a broad range (5%–75%) of malignant risk and accurately informing definitive management poses a challenge. Advancements in molecular testing of fine-needle aspiration biopsies have improved preoperative diagnostic accuracy and prognostication. For indeterminate nodules, such testing ideally will reduce the need for surgery for benign nodules and potentially guide appropriate extent of initial surgery for malignancy.
Le texte complet de cet article est disponible en PDF.Keywords : Indeterminate thyroid nodule, Gene mutations, Molecular testing, Mutational analysis, Gene expression classifier, Gene sequencing, microRNA classifier
Plan
Disclosures: The authors have no conflicts of interest or financial disclosures to declare. No financial support was received for the completion of this work. |
Vol 99 - N° 4
P. 587-598 - août 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?